Single-dose pharmacokinetics of flurbiprofen granules and tablets in healthy volunteers. 1989

C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
Medical Dept., Boots-Formenti, Milan, Italy.

The bioavailability of granules and tablet flurbiprofen in 100 mg single dose was crossover compared in 6 healthy volunteers (mean aged 26.8 years). The granules showed an earlier peaktime and a lower maximum concentration than the tablet. Area under the curve and half-time in terminal phase were similar, with the granule relative bioavailability of 0.98.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D005480 Flurbiprofen An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE. 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic Acid,Ansaid,Apo-Flurbiprofen,BTS-18322,Cebutid,Dobrofen,E-7869,Flubiprofen,Flugalin,Flurbiprofen Sodium,Fluriproben,Froben,Froben SR,Neo Artrol,Novo-Flurprofen,Nu-Flurbiprofen,Ocufen,Ocuflur,Strefen,ratio-Flurbiprofen,Apo Flurbiprofen,BTS 18322,BTS18322,E 7869,E7869,Novo Flurprofen,Nu Flurbiprofen,ratio Flurbiprofen
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
June 2014, International journal of clinical pharmacology and therapeutics,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
January 1995, European journal of clinical pharmacology,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
January 1985, Arzneimittel-Forschung,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
November 1980, Acta pharmacologica et toxicologica,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
November 2010, Journal of clinical pharmacology,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
January 2005, Clinical pharmacokinetics,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
January 1988, European journal of clinical pharmacology,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
September 2006, Clinical therapeutics,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
August 2013, International journal of clinical pharmacology and therapeutics,
C Benvenuti, and V Gambaro, and F Lodi, and C Scaroni, and G Bandi, and M Valenti
April 2012, Clinical pharmacology in drug development,
Copied contents to your clipboard!